Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 6INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 1Advanced Solid Tumor 1Advanced Pancreatic Cancer 1

Interventions

pembrolizumab 609Carboplatin 373Paclitaxel 283Cisplatin 267Gemcitabine 257Pemetrexed 194Nivolumab 192Bevacizumab 191Docetaxel 190Injections 167Cyclophosphamide 147atezolizumab 137Capecitabine 134Fluorouracil 133Oxaliplatin 132Dexamethasone 130Fulvestrant 115durvalumab 114130-nm albumin-bound paclitaxel 110fludarabine 100Cetuximab 100Rituximab 96Leucovorin 96venetoclax 89Lenalidomide 84enzalutamide 79Prednisone 79Ipilimumab 75Azacitidine 75Irinotecan 74

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × penpulimab × 1 year × Clear all
NCT05563480 2026-04-07

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2 Completed
47 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT06821503 2026-03-10

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Recruiting
72 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

NCT06825494 2025-12-18

Clinical Studies for the Treatment of Advanced Solid Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Recruiting
194 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡